{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:09:28Z","timestamp":1770970168555,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.eplepsyres.2019.106236","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:28:23Z","timestamp":1573039703000},"page":"106236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? \u2014 A case series"],"prefix":"10.1016","volume":"159","author":[{"given":"Bernhard J.","family":"Steinhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Blickhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Bernedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Dietmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassanai","family":"Intravooth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"Kornmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Stockinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke M.","family":"Staack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2019.106236_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eplepsyres.2018.06.002","article-title":"Brivaracetam-induced elevation of carbamazepine epoxide levels: a post-hoc analysis from the clinical development program","volume":"45","author":"Brodie","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.03.023","article-title":"Antiepileptic drugs induced hyponatremia: review and analysis of 560 hospitalized patients","volume":"143","author":"Intravooth","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0015","first-page":"1","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein","year":"2018","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0020","series-title":"Tegretol Tablets 100 mg, 200 mg, 400 mg, Summary of Product Characteristics","author":"Novartis","year":"2015"},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0025","series-title":"Poster Presented at: American Epilepsy Society 69th Annual Meeting: December 4-8","article-title":"Evaluation of the pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with partial-onset seizures","author":"Otoul","year":"2015"},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0030","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs \u2013 best practice guidelines for therapeutic drug monitoring.: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0035","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1528-1157.1993.tb02117.x","article-title":"Carbamazepine-valoctamide interaction in epileptic patients: in vitro\/in vivo correlation","volume":"34","author":"Pisani","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00007691-198412000-00005","article-title":"Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects","volume":"6","author":"Riva","year":"1984","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0045","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1469-8749.1984.tb08169.x","article-title":"Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side effects in children with epilepsy","volume":"26","author":"Schoeman","year":"1984","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00007691-199412000-00001","article-title":"Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy","volume":"16","author":"Semah","year":"1994","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286419873518","article-title":"Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience","volume":"12","author":"Steinhoff","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756285617742081","article-title":"Brivaracetam: a novel antiepileptic drug for focal-onset seizures","volume":"11","author":"Stephen","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eplepsyres.2015.03.003","article-title":"Brivaracetam and carbamazepine interaction in healthy subjects and in vitro","volume":"113","author":"Stockis","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2016.11.001","article-title":"Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration","volume":"128","author":"Stockis","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0075","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archneur.1990.00530080072013","article-title":"Carbamazepine-10,11-epoxide in epilepsy: a pilot study","volume":"47","author":"Tomson","year":"1990","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0920-1211(92)90049-Y","article-title":"Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11-epoxide","volume":"11","author":"Warner","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2019.106236_bib0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1081\/CLT-120015836","article-title":"Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide","volume":"40","author":"Winnicka","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121119304334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121119304334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:41:19Z","timestamp":1760276479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121119304334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":17,"alternative-id":["S0920121119304334"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2019.106236","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? \u2014 A case series","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2019.106236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106236"}}